Myriad Genetics is a leading molecular diagnostic company dedicated to making a difference in patient’s lives through the discovery and commercialization of transformative tests to assess a person’s risk of developing disease, guide treatment decisions and assess risk of disease progression and recurrence.
The goal of Myriad is to make a difference in patient’s lives and for the past twenty years, the Company’s strategy has been guided by this mission. To accomplish this, Myriad is focused on revolutionizing patient care through the development and marketing of transformative tests which address pressing clinical needs across multiple medical specialties.
Over the last twenty years, Myriad has invested heavily in the education of patients and health care providers on the role genes and their related proteins play in disease. Almost one million patients have already benefited from Myriad’s informative testing, which helps physicians better manage their health care.
Today, Myriad continues to build on this strong tradition. It is working to expand its reach by introducing newgenetic tests and molecular diagnostic tests for a number of diseases. The Company is also focused on extending our mission internationally, in an effort to broaden our geographic footprint and provide critical information to more patients and healthcare providers.